Harvard Bioscience (HBIO) Inventory Average (2011 - 2026)
Harvard Bioscience (HBIO) posted quarterly Inventory Average of $21.5 million for Q1 2026, down 6.62% year-over-year from $23.0 million in Q1 2025, and up 1.42% quarter-over-quarter from $21.2 million in Q4 2025.
Harvard Bioscience (HBIO) Inventory Average (2011 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Inventory Average for 16 consecutive years, with $21.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 6.62% year-over-year to $21.5 million; the TTM figure through Mar 2026 stood at $21.5 million (down 6.62% YoY), while the FY2025 annual figure was $22.0 million, down 8.15% from the prior year.
- Inventory Average grew to $21.5 million in Q1 2026 per HBIO's latest filing, from $21.2 million in the prior quarter.
- Across five years, Inventory Average topped out at $29.0 million in Q2 2022 and bottomed at $21.2 million in Q4 2025.
- Historically, Inventory Average has averaged $25.0 million across 5 years, with a median of $25.3 million in 2023.
- Annual changes were most pronounced in 2022 — Inventory Average advanced 25.28% — and 2025, when it fell 14.2%.
- Harvard Bioscience's Inventory Average stood at $26.3 million in 2022, then declined by 3.85% to $25.3 million in 2023, then fell by 2.57% to $24.6 million in 2024, then fell by 13.86% to $21.2 million in 2025, then increased by 1.42% to $21.5 million in 2026.
- Business Quant data shows HBIO's Inventory Average at $21.5 million in Q1 2026, $21.2 million in Q4 2025, and $21.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.99 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 3.34 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 2.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 928.84 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 4.74 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 450.00 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 1.06 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 886.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 2.29 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 22.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.22 Mn |
| Mar 31, 2026 | 21.51 Mn |
| Dec 31, 2025 | 21.20 Mn |
| Sep 30, 2025 | 21.93 Mn |
| Jun 30, 2025 | 22.54 Mn |
| Mar 31, 2025 | 23.03 Mn |
| Dec 31, 2024 | 24.62 Mn |
| Sep 30, 2024 | 25.56 Mn |
| Jun 30, 2024 | 24.63 Mn |
| Mar 31, 2024 | 24.43 Mn |
| Dec 31, 2023 | 25.27 Mn |
| Sep 30, 2023 | 25.95 Mn |
| Jun 30, 2023 | 26.48 Mn |
| Mar 31, 2023 | 26.65 Mn |
| Dec 31, 2022 | 26.28 Mn |
| Sep 30, 2022 | 27.73 Mn |
| Jun 30, 2022 | 29.02 Mn |
| Mar 31, 2022 | 28.15 Mn |
| Dec 31, 2021 | 26.78 Mn |
| Sep 30, 2021 | 25.34 Mn |